Výsledky vyhledávání - "Frederick C Kass"

Cardiac safety results from a phase II, open-label, multicenter, pilot study of two docetaxel-based regimens plus bevacizumab for the adjuvant treatment of subjects with node-positive or high-risk node-negative breast cancer

Autor: Frederick C Kass, Gladys Rodriguez, Dennis J. Slamon, Sara A. Hurvitz, Frederick P. Smith, Barrett H Childs, Linda D. Bosserman, David Chan, Christopher T Hagenstad

Publikováno v: SpringerPlus
SpringerPlus, vol 3, iss 1

PurposeAdding antiangiogenic therapy to standard chemotherapy has improved response rates and progression-free survival in metastatic breast cancer (BC) patients. This phase II study evaluated cardiac safety of bevacizumab with/without trastuzumab wi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40f3564c1e91fc8108a04cc13a1b9c64
http://europepmc.org/articles/PMC4031367

Zobrazit plný text záznamu

Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2): Analysis of Cancer and Leukemia Group B Protocol 8935

Autor: Mark R. Green, Frederick C. Kass, Mark Langer, Parvesh Kumar, Stephen L. Seagren, David J. Sugarbaker, Walter L. Eaton, Anthony D. Elias, Leslie J. Kohman, James E. Herndon

Publikováno v: Cancer. 77:2393-2399

BACKGROUND. The impact of sequential trimodality therapy on the pattern of first site disease failure in pathologic Stage IIIA (N2) nonsmall cell lung carcinoma (NSCLC) was analyzed. METHODS. Seventy-four eligible patients with histologically documen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::65579f199add4867cc9d407e0c9ef76b
https://doi.org/10.1002/(sici)1097-0142(19960601)77:11<2393::aid-cncr31>3.0.co

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání